Aptinyx Inc. [NASDAQ: APTX] stock went on an upward path that rose over 6.04% on Wednesday, amounting to a one-week price increase of more than 6.04%. The company report on December 21, 2020 that Aptinyx to Present at the 39th Annual J.P. Morgan Healthcare Conference.
Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, announced that the company will present virtually at the 39th Annual J.P. Morgan Healthcare Conference. Norbert Riedel, Ph.D., chief executive officer, is scheduled to present on Thursday, January 14, 2021 at 9:10 a.m. Eastern Time.
A live webcast of the presentation will be available to view on the “Events and Presentations” page in the “Investors & Media” section of Aptinyx’s website at https://ir.aptinyx.com and will be archived on Aptinyx’s website for 30 days following the event.
Over the last 12 months, APTX stock rose by 6.04%. The average equity rating for APTX stock is currently 1.80, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $247.54 million, with 46.98 million shares outstanding and 27.45 million shares in the current float. Compared to the average trading volume of 1.59M shares, APTX stock reached a trading volume of 1228136 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Aptinyx Inc. [APTX]:
Piper Sandler have made an estimate for Aptinyx Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on October 27, 2020. While these analysts kept the previous recommendation, SunTrust raised their target price to Buy. The new note on the price target was released on July 01, 2020, representing the official price target for Aptinyx Inc. stock.
The Average True Range (ATR) for Aptinyx Inc. is set at 0.24, with the Price to Sales ratio for APTX stock in the period of the last 12 months amounting to 99.02. The Price to Book ratio for the last quarter was 1.65, with the Price to Cash per share for the same quarter was set at 1.62.
APTX Stock Performance Analysis:
Aptinyx Inc. [APTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.04. With this latest performance, APTX shares gained by 14.88% in over the last four-week period, additionally sinking by -9.18% over the last 6 months – not to mention a rise of 6.04% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APTX stock in for the last two-week period is set at 59.81, with the RSI for the last a single of trading hit 63.78, and the three-weeks RSI is set at 57.28 for Aptinyx Inc. [APTX]. The present Moving Average for the last 50 days of trading for this stock 3.43, while it was recorded at 3.70 for the last single week of trading, and 3.46 for the last 200 days.
Insight into Aptinyx Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Aptinyx Inc. [APTX] shares currently have an operating margin of -1624.78. Aptinyx Inc.’s Net Margin is presently recorded at -1564.73.
Return on Total Capital for APTX is now -47.57, given the latest momentum, and Return on Invested Capital for the company is -45.81. Return on Equity for this stock declined to -45.81, with Return on Assets sitting at -37.34.
Reflecting on the efficiency of the workforce at the company, Aptinyx Inc. [APTX] managed to generate an average of -$1,335,116 per employee. Receivables Turnover for the company is 7.18 with a Total Asset Turnover recorded at a value of 0.02.Aptinyx Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 26.50 and a Current Ratio set at 26.50.
APTX Stock EPS
With the latest financial reports released by the company, Aptinyx Inc. posted -0.41/share EPS, while the average EPS was predicted by analysts to be reported at -0.56/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 26.80%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for APTX.
Aptinyx Inc. [APTX] Insider Position Details
There are presently around $102 million, or 49.80% of APTX stock, in the hands of institutional investors. The top three institutional holders of APTX stocks are: BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC with ownership of 5,558,425, which is approximately 0% of the company’s market cap and around 3.72% of the total institutional ownership; ADAMS STREET PARTNERS LLC, holding 5,305,872 shares of the stock with an approximate value of $19.31 million in APTX stocks shares; and NEW LEAF VENTURE PARTNERS, L.L.C., currently with $11.98 million in APTX stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Aptinyx Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 28 institutional holders increased their position in Aptinyx Inc. [NASDAQ:APTX] by around 1,145,352 shares. Additionally, 33 investors decreased positions by around 1,109,602 shares, while 15 investors held positions by with 25,756,411 shares. The mentioned changes placed institutional holdings at 28,011,365 shares, according to the latest SEC report filing. APTX stock had 6 new institutional investments in for a total of 55,614 shares, while 10 institutional investors sold positions of 325,947 shares during the same period.